In 2022, a breast cancer patient filed a writ petition before the Kerala High Court, stating that one of the drugs prescribed for her condition, Ribociclib, was "too expensive and unavailable at an affordable price" because it was patented.
57 Hearings And An Unanswered Call For Affordable Drugs: Court Seeks Reply
In 2022, a breast cancer patient filed a writ petition before the Kerala High Court, stating that one of the drugs prescribed for her condition, Ribociclib, was "too expensive and unavailable at an affordable price" because it was patented.
Published: 17 July 2026
This article was originally published by an external source. Read the full story at the source.
Read Full Article at Source ↗